Filing Flows

Filing Flows › Comparisons › TNXP vs ASMB

Tonix Pharmaceuticals Holding vs Assembly Biosciences: TNXP and ASMB compared

Tonix Pharmaceuticals Holding is the larger company: $13.5M of revenue in its latest quarter (Q2 2026) against $13.4M for Assembly Biosciences (Q2 2026). Tonix Pharmaceuticals Holding is growing faster (+578% against +39% a year earlier). Assembly Biosciences is more profitable, with an operating margin of -47.4% against -314.1%.

Tonix Pharmaceuticals Holding vs Assembly Biosciences, latest quarterTonix Pharmaceuticals Holding vs Assembly Biosciences, latest quarterTonix Pharmaceuticals Holding (TNXP)Assembly Biosciences (ASMB)Revenue$13.5M$13.4MRevenue growth, Y/Y+578%+39%Operating margin-314.1%-47.4%Net margin-299.4%-28.8%

Where the money goes: TNXP and ASMB

Tonix Pharmaceuticals Holding (TNXP) · Q2 2026

Tonix Pharmaceuticals Holding, Q2 2026: revenue $13.5M (+578% year over year), operating margin -314.1%, net loss $40.6M, operating cash flow −$42.2M. The chart follows the revenue to costs, profit and cash.

Assembly Biosciences (ASMB) · Q2 2026

Assembly Biosciences, Q2 2026: revenue $13.4M (+39% year over year), operating margin -47.4%, net loss $3.9M, operating cash flow −$15.5M. The chart follows the revenue to costs, profit and cash.

Tonix Pharmaceuticals Holding revenue by segment, Q2 2026Tonix Pharmaceuticals Holding revenue by segment, Q2 2026Tonmya$11.0MZembrace Symtouch$2.0MTosymra$594K
Tonix Pharmaceuticals Holding (TNXP)Assembly Biosciences (ASMB)
Latest quarterQ2 2026Q2 2026
Revenue$13.5M$13.4M
Revenue growth, Y/Y+578%+39%
Operating margin-314.1%-47.4%
Net earnings−$40.6M−$3.9M
Net margin-299.4%-28.8%
Operating cash flow−$42.2M−$15.5M

Where the revenue comes from

Tonix Pharmaceuticals Holding

Questions

Which is bigger, Tonix Pharmaceuticals Holding or Assembly Biosciences?

Tonix Pharmaceuticals Holding is the larger company: $13.5M of revenue in its latest quarter (Q2 2026) against $13.4M for Assembly Biosciences (Q2 2026).

Is Tonix Pharmaceuticals Holding or Assembly Biosciences growing faster?

Tonix Pharmaceuticals Holding is growing faster (+578% against +39% a year earlier).

Which is more profitable, Tonix Pharmaceuticals Holding or Assembly Biosciences?

Assembly Biosciences is more profitable, with an operating margin of -47.4% against -314.1%.

More: Tonix Pharmaceuticals Holding earnings · how Tonix Pharmaceuticals Holding makes money · Assembly Biosciences earnings · how Assembly Biosciences makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.